24 November 2020
It highlights the importance of biotech and how it can contribute to New Zealand’s economic growth and diversification, as well as its ability to help make New Zealand cleaner, healthier and more prosperous.
Read More
11 November 2020
Medicinal cannabis experts say the emerging industry in New Zealand is still being plagued by misinformed perception and over-regulation. Source: Newshub
Read More
10 November 2020
The landmark BioTechNZ study analysed the state of biotechnology and its impact and benefits for the New Zealand economy and society.
Read More
06 November 2020
There is no question, 2020 has been a tough and interesting year for everyone. However, despite the challenges, this did not stop the BioTech team; we worked hard and were hugely productive during the lockdown periods.
Read More
“Alert Level 1 is exciting news for large and important events like ours,” says Dr Zahra Champion, Executive Director of BioTechNZ and MedCan Summit 2020 organiser in response to the Prime Minister’s confirmation that Auckland will join the rest of the country on Level 1 at 12.59pm on Wednesd
October 5, 2020
Minister Jacinda Ardern and Director-General of Health Dr Ashley Bloomfield provided a COVID-19 update on COVID-19 daily and both use terminology like genomic testing, genomic sequencing, DNA, vaccines, viruses, cells, antibodies, epidemiology, microbiology and handwashing, masks and NZ COVID Trace
September 18, 2020
It’s only two months until New Zealand’s first medicinal cannabis summit, MedCan 2020, with organisers saying the economic potential of New Zealand’s most exciting sunrise industry is more important than ever before. MedCan Summit 2020 will take place on Monday 9 and Tuesday 10 N
September 7, 2020
Many friends and colleagues attended the Aroa Biosurgery (ASX:ARX) listing on the ASX, ceremony and celebration at the end of July. Aroa is a soft-tissue regeneration company, founded in 2008.“You all know biotechnology is an important part of New Zealand's future” Peter Hodgson, Rese
August 18, 2020
For those members who were unable to join us for the Annual Meeting on 21st July 2020, you can view the meeting presentation here.
July 22, 2020
The Precautionary Principle, there are many definitions, but the most common expression today claims that a practice, substance or technology must be banned or prohibited if it cannot be proven (with certainty) to be safe. Rather than trying to reduce exposure to risks or solve problems with innova
July 3, 2020
Congratulations to our Neonatal expert Professor Jane Harding as she is now one of the Dame Companions of the New Zealand Order of Merit (NZOM). Congratulations also to medical researcher Professor Robert Elliott who has been appointed Knight Companions of the NZOM. Well deserved recog
June 3, 2020
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis. Pictor has received a grant of $500,000 from the $25 million MBIE COVID-19 Innovation Acceleration Fund,
May 18, 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
May 8, 2020